An Efficacy and Safety Study of HCP1105 Capsule in Combined Hyperlipidemic Patients With High Risk for Coronary Heart Disease (CHD): A Randomized,Double-blind, Multicenter, Phase 3 Study
Latest Information Update: 06 Nov 2021
At a glance
- Drugs HCP 1105 (Primary) ; HGP 0816
- Indications Hyperlipidaemia
- Focus Therapeutic Use
- Sponsors Hanmi Pharmaceutical
Most Recent Events
- 22 Sep 2015 New trial record